ADVENT TECHNOLOGIES HOLDINGS (ADN)
US00788A2042 - Common Stock
ADN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 90 industry peers in the Electrical Equipment industry. ADN has a bad profitability rating. Also its financial health evaluation is rather negative. ADN shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
ADN had negative earnings in the past year.
In the past year ADN has reported a negative cash flow from operations.
ADN had negative earnings in each of the past 5 years.
In the past 5 years ADN always reported negative operating cash flow.
1.2 Ratios
ADN's Return On Assets of -405.09% is on the low side compared to the rest of the industry. ADN is outperformed by 94.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -405.09% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-100.37%
ROA(5y)-96.93%
ROE(3y)-220.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for ADN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ADN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ADN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ADN has more shares outstanding
ADN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
ADN has an Altman-Z score of -29.75. This is a bad value and indicates that ADN is not financially healthy and even has some risk of bankruptcy.
ADN has a worse Altman-Z score (-29.75) than 94.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -29.75 |
ROIC/WACCN/A
WACC9.85%
2.3 Liquidity
A Current Ratio of 0.44 indicates that ADN may have some problems paying its short term obligations.
The Current ratio of ADN (0.44) is worse than 94.38% of its industry peers.
ADN has a Quick Ratio of 0.44. This is a bad value and indicates that ADN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ADN (0.31) is worse than 94.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.44 | ||
| Quick Ratio | 0.31 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 51.72% over the past year.
Looking at the last year, ADN shows a quite strong growth in Revenue. The Revenue has grown by 9.01% in the last year.
ADN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.03% yearly.
EPS 1Y (TTM)51.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.09%
Revenue 1Y (TTM)9.01%
Revenue growth 3Y76.57%
Revenue growth 5Y67.03%
Sales Q2Q%-27.48%
3.2 Future
ADN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.75% yearly.
Based on estimates for the next years, ADN will show a very strong growth in Revenue. The Revenue will grow by 633.14% on average per year.
EPS Next Y98.1%
EPS Next 2Y44.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2705.94%
Revenue Next 2Y633.14%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ADN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 72.28, which means the current valuation is very expensive for ADN.
ADN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ADN is cheaper than 64.04% of the companies in the same industry.
ADN is valuated expensively when we compare the Price/Forward Earnings ratio to 24.00, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 72.28 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ADN's earnings are expected to grow with 44.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.75%
EPS Next 3YN/A
5. Dividend
5.1 Amount
ADN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ADVENT TECHNOLOGIES HOLDINGS
NASDAQ:ADN (11/22/2024, 8:21:46 PM)
After market: 7.29 -0.01 (-0.14%)7.3
-0.31 (-4.07%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap19.27M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 72.28 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -405.09% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.44 | ||
| Quick Ratio | 0.31 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)51.72%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y98.1%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.01%
Revenue growth 3Y76.57%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y